BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND MUTYH, MYH, 4595, ENSG00000132781, hMYH, MGC4416, MYHbeta
14 results:

  • 1. Detection Rate and Spectrum of Pathogenic Variations in a Cohort of 83 Patients with Suspected Hereditary Risk of kidney Cancer.
    Ouedraogo ZG; Ceruti F; Lepage M; Gay-Bellile M; Uhrhammer N; Ponelle-Chachuat F; Bidet Y; Privat M; Cavaillé M
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002934
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk.
    Yang Y; Zhang G; Hu C; Luo W; Jiang H; Liu S; Yang H
    BMC Urol; 2022 Nov; 22(1):196. PubMed ID: 36451132
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases.
    Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
    JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Small cell variant of chromophobe renal cell carcinoma: Clinicopathologic and molecular-genetic analysis of 10 cases.
    Rogala J; Kojima F; Alaghehbandan R; Ptakova N; Bravc A; Bulimbasic S; Perez Montiel D; Slisarenko M; Ali L; Kuthi L; Pivovarcikova K; Michalova K; Bartovic B; Bartos Vesela A; Dolejsova O; Michal M; Hes O
    Bosn J Basic Med Sci; 2022 Jul; 22(4):531-539. PubMed ID: 35276058
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.
    Hol JA; Kuiper RP; van Dijk F; Waanders E; van Peer SE; Koudijs MJ; Bladergroen R; van Reijmersdal SV; Morgado LM; Bliek J; Lombardi MP; Hopman S; Drost J; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MCJ
    J Clin Oncol; 2022 Jun; 40(17):1892-1902. PubMed ID: 35230882
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma.
    Santos M; Lanillos J; Roldan-Romero JM; Caleiras E; Montero-Conde C; Cascón A; Climent MA; Anguera G; Hernando S; Laínez N; Robledo M; Robles L; de Velasco G; García-Donas J; Rodriguez-Antona C
    Genet Med; 2021 Apr; 23(4):698-704. PubMed ID: 33442023
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma.
    Meng H; Jiang X; Cui J; Yin G; Shi B; Liu Q; Xuan H; Wang Y
    Biomed Res Int; 2020; 2020():2495157. PubMed ID: 33062672
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Superiority of rat over murine model for studies on the evolution of cancer genome.
    Akatsuka S; Li GH; Toyokuni S
    Free Radic Res; 2018 Dec; 52(11-12):1323-1327. PubMed ID: 29669465
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.
    Royer-Pokora B; Beier M; Brandt A; Duhme C; Busch M; de Torres C; Royer HD; Mora J
    Cancer Med; 2018 Apr; 7(4):1359-1368. PubMed ID: 29542868
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A case series of intestinal adenomatous polyposis of unidentified etiology; a late effect of irradiation?
    Rigter LS; Kallenberg FG; Bastiaansen B; van Os TA; van Leeuwen FE; van Leerdam ME; Dekker E
    BMC Cancer; 2016 Nov; 16(1):862. PubMed ID: 27821077
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk of extracolonic cancers for people with biallelic and monoallelic mutations in mutyh.
    Win AK; Reece JC; Dowty JG; Buchanan DD; Clendenning M; Rosty C; Southey MC; Young JP; Cleary SP; Kim H; Cotterchio M; Macrae FA; Tucker KM; Baron JA; Burnett T; Le Marchand L; Casey G; Haile RW; Newcomb PA; Thibodeau SN; Hopper JL; Gallinger S; Winship IM; Lindor NM; Jenkins MA
    Int J Cancer; 2016 Oct; 139(7):1557-63. PubMed ID: 27194394
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cancer risks for monoallelic mutyh mutation carriers with a family history of colorectal cancer.
    Win AK; Cleary SP; Dowty JG; Baron JA; Young JP; Buchanan DD; Southey MC; Burnett T; Parfrey PS; Green RC; Le Marchand L; Newcomb PA; Haile RW; Lindor NM; Hopper JL; Gallinger S; Jenkins MA
    Int J Cancer; 2011 Nov; 129(9):2256-62. PubMed ID: 21171015
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Report of a family segregating mutations in both the APC and MSH2 genes: juvenile onset of colorectal cancer in a double heterozygote.
    Uhrhammer N; Bignon YJ
    Int J Colorectal Dis; 2008 Nov; 23(11):1131-5. PubMed ID: 18629513
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Laparoscopic partial nephrectomy for selected central tumours: omitting the bolster.
    Weight CJ; Lane BR; Gill IS
    BJU Int; 2007 Aug; 100(2):375-8. PubMed ID: 17617142
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.